Page 22 - Pathogen Readiness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail BOSTON - Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of COVID-19 following SARS-CoV-2 infection. New research led by investigators at Massachusetts General Hospital (MGH) and published in Cell reveals lower than expected transfer of protective SARS-CoV-2 antibodies via the placenta from mothers who are infected in the third trimester. The cause may be alterations to these antibodies after they're produced--a process called glycosylation. The results expand on the team's recent findings published in JAMA Network O...

By JACQUELINE MITCHELL | Beth Israel Deaconess December 15, 2020Research This article is part of Harvard Medical School’s   of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19. Since the novel coronavirus emerged at the end of 2019, scientists around the world, including immunologist Dan Barouch, the William Bosworth Castle Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, have been developing vaccines to protect against COVID-19 and to put an end to the pandemic. As o...

Experience in early hotspots shows need for collaboration, coordination   Bruce Walker, the Phillip T. and Susan M. Ragon Professor of Medicine at Massachusetts General Hospital and co-director of MassCPR, gave a brief overview of the unprecedented, rapid development of vaccines for SARS-CoV-2, noting that many have wondered how the vaccines can have been developed so quickly without compromising safety. “The answers to that are not due to cutting corners but really to tremendous scientific advances—and to some decisions that were made early on to accelerate those aspects that co...